| Title |
Registre Canadien de la SMD |
| Protocole ID |
Registre SMD |
| ClinicalTrials.gov ID |
|
| Cancer Type(s) |
Myelodysplastic Syndrome |
| Phase |
|
| Stage |
|
| Study Type |
|
| Drug |
|
| Institution |
CHU DE QUEBEC – UNIVERSITE LAVAL
 HOPITAL DE L'ENFANT-JESUS
1401 18e Rue, Québec, QC, G1J 1Z4
|
| City |
Québec |
| Principal Investigator |
Dr. Robert Delage
|
| Coordinator |
Linda Vallée
418-649-0252 poste 66602
|
| Status |
Recruiting |
| Activation Date |
|
| Eligibility Criteria |
- Diagnostic de SMD ou LMMC confirmé par moelle < 3 mois
- Blastes < 30 %
|
| Exclusion Criteria |
|
| |
|
Groupe d'étude en oncologie du Québec